Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 317950, 11 pages
http://dx.doi.org/10.1155/2012/317950
Review Article

Leptospira and Inflammation

1Laboratório de Imunofarmacologia, Fundacão Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil
2Departamento de Biologia Celular e Molecular, Instituto de Biologia, Universidade Federal Fluminense, Niterói 24020-150, Brazil
3Departamento de Medicina Interna, Faculdade de Ciências Medicas, Universidade do Estado do Rio de Janeiro, Rio de Janeiro 20550-900, Brazil

Received 26 July 2012; Revised 25 September 2012; Accepted 27 September 2012

Academic Editor: Helen C. Steel

Copyright © 2012 C. F. Gonçalves-de-Albuquerque et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Adler and A. de la Peña Moctezuma, “Leptospira and leptospirosis,” Veterinary Microbiology, vol. 140, no. 3-4, pp. 287–296, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. R. Bharti, J. E. Nally, J. N. Ricaldi et al., “Leptospirosis: a zoonotic disease of global importance,” The Lancet Infectious Diseases, vol. 3, no. 12, pp. 757–771, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Dolhnikoff, T. Mauad, E. P. Bethlem, and C. R. R. Carvalho, “Pathology and pathophysiology of pulmonary manifestations in leptospirosis,” Brazilian Journal of Infectious Diseases, vol. 11, no. 1, pp. 142–148, 2007. View at Google Scholar · View at Scopus
  4. R. B. Reis, G. S. Ribeiro, R. D. M. Felzemburgh et al., “Impact of environment and social gradient on Leptospira infection in urban slums,” PLoS Neglected Tropical Diseases, vol. 2, no. 4, article e228, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. I. Ko, M. Galvão Reis, C. M. Ribeiro Dourado, W. D. Johnson, and L. W. Riley, “Urban epidemic of severe leptospirosis in Brazil,” The Lancet, vol. 354, no. 9181, pp. 820–825, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. W.H.O., Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control, W.H. Organization and I.L. Society, WHO library Cataloguing-in-Publication Data Malta, 2003.
  7. G. Pappas, P. Papadimitriou, V. Siozopoulou, L. Christou, and N. Akritidis, “The globalization of leptospirosis: worldwide incidence trends,” International Journal of Infectious Diseases, vol. 12, no. 4, pp. 351–357, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. T. D. Faria, M. S. Calderwood, D. A. Athanazio et al., “Carriage of Leptospira interrogans among domestic rats from an urban setting highly endemic for leptospirosis in Brazil,” Acta Tropica, vol. 108, no. 1, pp. 1–5, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. C. A. Ganoza, M. A. Matthias, M. Saito, M. Cespedes, E. Gotuzzo, and J. M. Vinetz, “Asymptomatic renal colonization of humans in the Peruvian Amazon by Leptospira,” PLoS Neglected Tropical Diseases, vol. 4, no. 2, article e612, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. R. U. M. Palaniappan, S. Ramanujam, and Y. F. Chang, “Leptospirosis: pathogenesis, immunity, and diagnosis,” Current Opinion in Infectious Diseases, vol. 20, no. 3, pp. 284–292, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. G. Songer and A. B. Thiermann, “Leptospirosis,” Journal of the American Veterinary Medical Association, vol. 193, no. 10, pp. 1250–1254, 1988. View at Google Scholar · View at Scopus
  12. P. N. Levett, “Leptospirosis: a forgotten zoonosis?” Clinical and Applied Immunology Reviews, vol. 4, no. 6, pp. 435–448, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Baranton and D. Postic, “Trends in leptospirosis epidemiology in France. Sixty-six years of passive serological surveillance from 1920 to 2003,” International Journal of Infectious Diseases, vol. 10, no. 2, pp. 162–170, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Van Crevel, P. Speelman, C. Gravekamp, and W. J. Terpstra, “Leptospirosis in travelers,” Clinical Infectious Diseases, vol. 19, no. 1, pp. 132–134, 1994. View at Google Scholar · View at Scopus
  15. M. A. Martínez García, A. De Diego Damiá, R. M. Villanueva, and J. L. López Hontagas, “Pulmonary involvement in leptospirosis,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 19, no. 6, pp. 471–474, 2000. View at Google Scholar · View at Scopus
  16. F. Dorigatti, M. K. C. Brunialti, E. C. Romero, E. G. Kallas, and R. Salomão, “Leptospira interrogans activation of peripheral blood monocyte glycolipoprotein demonstrated in whole blood by the release of IL-6,” Brazilian Journal of Medical and Biological Research, vol. 38, no. 6, pp. 909–914, 2005. View at Google Scholar · View at Scopus
  17. A. J. A. McBride, D. A. Athanazio, M. G. Reis, and A. I. Ko, “Leptospirosis,” Current Opinion in Infectious Diseases, vol. 18, no. 5, pp. 376–386, 2005. View at Google Scholar · View at Scopus
  18. E. L. Gouveia, J. Metcalfe, A. L. F. De Carvalho et al., “Leptospirosis-associated severe pulmonary hemorrhagic syndrome, Salvador, Brazil,” Emerging Infectious Diseases, vol. 14, no. 3, pp. 505–508, 2008. View at Google Scholar · View at Scopus
  19. K. V. Evangelista and J. Coburn, “Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses,” Future Microbiology, vol. 5, no. 9, pp. 1413–1425, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Dobrina, E. Nardon, E. Vecile, M. Cinco, and P. Patriarca, “Leptospira icterohemorrhagiae and leptospire peptidolgycans induce endothelial cell adhesiveness for polymorphonuclear leukocytes,” Infection and Immunity, vol. 63, no. 8, pp. 2995–2999, 1995. View at Google Scholar · View at Scopus
  21. Y. Sekkach, H. Qaçif, M. Jira, M. El qatni, N. El omri, and D. Ghafir, “Acute respiratory distress revelated asever pulmonary leptospirosis,” Revue de Medecine Interne, vol. 28, no. 1, pp. 48–51, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. L. T. O. Nascimento, A. I. Ko, E. A. L. Martins et al., “Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis,” Journal of Bacteriology, vol. 186, no. 7, pp. 2164–2172, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. S. X. Ren, G. Fu, X. G. Jiang et al., “Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing,” Nature, vol. 422, no. 6934, pp. 888–893, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Vijayachari, A. P. Sugunan, and A. N. Shriram, “Leptospirosis: an emerging global public health problem,” Journal of Biosciences, vol. 33, no. 4, pp. 557–569, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Nalam, A. Ahmed, S. M. Devi et al., “Genetic affinities within a large global collection of pathogenic Leptospira: implications for strain identification and molecular epidemiology,” PLoS ONE, vol. 5, no. 8, Article ID e12637, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Koizumi and H. Watanabe, “Identification of a novel antigen of pathogenic Leptospira spp. that reacted with convalescent mice sera,” Journal of Medical Microbiology, vol. 52, no. 7, pp. 585–589, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Gamberini, R. M. Gómez, M. V. Atzingen et al., “Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis,” FEMS Microbiology Letters, vol. 244, no. 2, pp. 305–313, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. D. A. Athanazio, E. F. Silva, C. S. Santos et al., “Rattus norvegicus as a model for persistent renal colonization by pathogenic Leptospira interrogans,” Acta Tropica, vol. 105, no. 2, pp. 176–180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J. B. Baseman and C. D. Cox, “Intermediate energy metabolism of Leptospira,” Journal of Bacteriology, vol. 97, no. 3, pp. 992–1000, 1969. View at Google Scholar · View at Scopus
  30. N. Stern, E. Shenberg, and A. Tietz, “Studies on the metabolism of fatty acids in Leptospira: the biosynthesis of delta 9- and delta 11-monounsaturated acids,” European Journal of Biochemistry, vol. 8, no. 1, pp. 101–108, 1969. View at Google Scholar · View at Scopus
  31. P. Ristow, P. Bourhy, S. Kerneis et al., “Biofilm formation by saprophytic and pathogenic leptospires,” Microbiology, vol. 154, no. 5, pp. 1309–1317, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. T. R. Fraga, A. S. Barbosa, and L. Isaac, “Leptospirosis: aspects of innate immunity, immunopathogenesis and immune evasion from the complement system,” Scandinavian Journal of Immunology, vol. 73, no. 5, pp. 408–419, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. P. A. Cullen, X. Xu, J. Matsunaga et al., “Surfaceome of Leptospira spp,” Infection and Immunity, vol. 73, no. 8, pp. 4853–4863, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. E. S. Shang, M. M. Exner, T. A. Summers et al., “The rare outer membrane protein, OmpL1, of pathogenic Leptospira species is a heat-modifiable porin,” Infection and Immunity, vol. 63, no. 8, pp. 3174–3181, 1995. View at Google Scholar · View at Scopus
  35. M. Pinne and D. A. Haake, “A comprehensive approach to identification of surface-exposed, outer membrane-spanning proteins of Leptospira interrogans,” PLoS ONE, vol. 4, no. 6, Article ID e6071, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. T. R. Fraga, R. M. Chura-Chambi, A. P. Gonçales et al., “Refolding of the recombinant protein OmpA70 from Leptospira interrogans from inclusion bodies using high hydrostatic pressure and partial characterization of its immunological properties,” Journal of Biotechnology, vol. 148, no. 2-3, pp. 156–162, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Oliveira, Z. M. de Morais, A. P. Gonçales, E. C. Romero, S. A. Vasconcellos, and A. L. T. O. Nascimento, “Characterization of novel OmpA-like protein of Leptospira interrogans that binds extracellular matrix molecules and plasminogen,” PLoS ONE, vol. 6, no. 7, Article ID e21962, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Ito and R. Yanagawa, “Leptospiral attachment to extracellular matrix of mouse fibroblast (L929) cells,” Veterinary Microbiology, vol. 15, no. 1-2, pp. 89–96, 1987. View at Google Scholar · View at Scopus
  39. D. D. Thomas and L. M. Higbie, “In vitro association of leptospires with host cells,” Infection and Immunity, vol. 58, no. 3, pp. 581–585, 1990. View at Google Scholar · View at Scopus
  40. Y. Liu, W. Zheng, L. Li, Y. Mao, and J. Yan, “Pathogenesis of leptospirosis: interaction of Leptospira interrogans with in vitro cultured mammalian cells,” Medical Microbiology and Immunology, vol. 196, no. 4, pp. 233–239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. N. W. Charon and S. F. Goldstein, “Genetics of motility and chemotaxis of a fascinating group of bacteria: the spirochetes,” Annual Review of Genetics, vol. 36, pp. 47–73, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. D. D. Breiner, M. Fahey, R. Salvador, J. Novakova, and J. Coburn, “Leptospira interrogans binds to human cell surface receptors including proteoglycans,” Infection and Immunity, vol. 77, no. 12, pp. 5528–5536, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. H. A. Choy, M. M. Kelley, T. L. Chen, A. K. Møller, J. Matsunaga, and D. A. Haake, “Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen,” Infection and Immunity, vol. 75, no. 5, pp. 2441–2450, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. A. S. Barbosa, P. A. E. Abreu, F. O. Neves et al., “A newly identified leptospiral adhesin mediates attachment to laminin,” Infection and Immunity, vol. 74, no. 11, pp. 6356–6364, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Matsunaga, M. A. Barocchi, J. Croda et al., “Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily,” Molecular Microbiology, vol. 49, no. 4, pp. 929–945, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. H. A. Choy, M. M. Kelley, J. Croda et al., “The multifunctional LigB adhesin binds homeostatic proteins with potential roles in cutaneous infection by pathogenic Leptospira interrogans,” PLoS ONE, vol. 6, no. 2, Article ID e16879, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Koizumi and H. Watanabe, “Leptospiral immunoglobulin-like proteins elicit protective immunity,” Vaccine, vol. 22, no. 11-12, pp. 1545–1552, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. É. F. Silva, M. A. Medeiros, A. J. A. McBride et al., “The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis,” Vaccine, vol. 25, no. 33, pp. 6277–6286, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. S. M. Faisal, W. Yan, C. S. Chen, R. U. M. Palaniappan, S. P. McDonough, and Y. F. Chang, “Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters,” Vaccine, vol. 26, no. 2, pp. 277–287, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. M. L. Coutinho, H. A. Choy, M. M. Kelley et al., “A ligA three-domain region protects hamsters from lethal infection by Leptospira interrogans,” PLoS Neglected Tropical Diseases, vol. 5, no. 12, Article ID e1422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. B. Stevenson, H. A. Choy, M. Pinne et al., “Leptospira interrogans endostatin-like outer membrane proteins bind host fibronectin, laminin and regulators of complement,” PLoS ONE, vol. 2, no. 11, Article ID e1188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Verma, C. A. Brissette, A. A. Bowman, S. T. Shah, P. F. Zipfel, and B. Stevenson, “Leptospiral endostatin-like protein a is a bacterial cell surface receptor for human plasminogen,” Infection and Immunity, vol. 78, no. 5, pp. 2053–2059, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. P. Ristow, P. Bourhy, F. W. da Cruz McBride et al., “The OmpA-like protein Loa22 is essential for leptospiral virulence,” PLoS Pathogens, vol. 3, no. 7, p. e97, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Zhang, L. Bao, H. Zhu, B. Huang, and H. Zhang, “OmpA-like protein Loa22 from Leptospira interrogans serovar Lai is cytotoxic to cultured rat renal cells and promotes inflammatory responses,” Acta Biochimica et Biophysica Sinica, vol. 42, no. 1, pp. 70–79, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. S. H. Lee, S. Kim, S. C. Park, and M. J. Kim, “Cytotoxic activities of Leptospira interrogans hemolysin SphH as a pore-forming protein on mammalian cells,” Infection and Immunity, vol. 70, no. 1, pp. 315–322, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Picardeau, D. M. Bulach, C. Bouchier et al., “Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis,” PLoS ONE, vol. 3, no. 2, Article ID e1607, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. R. C. Johnson and P. Rogers, “Metabolism of leptospirae. I. Utilization of amino acids and purine, and pyrimidine bases,” Archives of Biochemistry and Biophysics, vol. 107, no. 3, pp. 459–470, 1964. View at Google Scholar · View at Scopus
  58. R. C. Johnson and J. K. Walby, “Cultivation of leptospires: fatty acid requirements,” Applied Microbiology, vol. 23, no. 5, pp. 1027–1028, 1972. View at Google Scholar · View at Scopus
  59. T. Shimizu, E. Matsusaka, and K. Takayanagi, “Biological activities of lipopolysaccharide-like substance (LLS) extracted from Leptospira interrogans serovar canicola strain Moulton,” Microbiology and Immunology, vol. 31, no. 8, pp. 727–735, 1987. View at Google Scholar · View at Scopus
  60. N. L. S. Que-Gewirth, A. A. Ribeiro, S. R. Kalb et al., “A methylated phosphate group and four amide-linked acyl chains in Leptospira interrogans lipid A: the membrane anchor of an unusual lipopolysaccharide that activates TLR2,” Journal of Biological Chemistry, vol. 279, no. 24, pp. 25420–25429, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. M. A. Nahori, E. Fournié-Amazouz, N. S. Que-Gewirth et al., “Differential TLR recognition of leptospiral lipid A and lipopolysaccharide in murine and human cells,” Journal of Immunology, vol. 175, no. 9, pp. 6022–6031, 2005. View at Google Scholar · View at Scopus
  62. T. Vinh, B. Adler, and S. Faine, “Glycolipoprotein cytotoxin from Leptospira interrogans serovar copenhageni,” Journal of General Microbiology, vol. 132, no. 1, pp. 111–123, 1986. View at Google Scholar · View at Scopus
  63. Y. Arimitsu, A. Moribayashi, and N. Goto, “Skin reaction to lipids from avirulent strain Shibaura of Leptospira interrogans serovar copenhageni,” Canadian Journal of Microbiology, vol. 35, no. 11, pp. 1009–1014, 1989. View at Google Scholar · View at Scopus
  64. T. Vinh, B. Adler, and S. Faine, “Ultrastructure and chemical composition of lipopolysaccharide extracted from Leptospira interrogans serovar copenhageni,” Journal of General Microbiology, vol. 132, no. 1, pp. 103–109, 1986. View at Google Scholar · View at Scopus
  65. T. Shimizu, E. Matsusaka, and N. Nagakura, “Chemical properties of lipopolysaccharide-like substance (LLS) extracted from Leptospira interrogans serovar canicola strain Moulton,” Microbiology and Immunology, vol. 31, no. 8, pp. 717–725, 1987. View at Google Scholar · View at Scopus
  66. B. Beutler, “Innate immune sensing of microbial infection: the mechanism and the therapeutic challenge,” Wiener Medizinische Wochenschrift, vol. 152, no. 21-22, pp. 547–551, 2002. View at Google Scholar · View at Scopus
  67. E. M. Creagh and L. A. J. O'Neill, “TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity,” Trends in Immunology, vol. 27, no. 8, pp. 352–357, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. T. Kawai and S. Akira, “TLR signaling,” Seminars in Immunology, vol. 19, no. 1, pp. 24–32, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. B. Verstak, P. Hertzog, and A. Mansell, “Toll-like receptor signalling and the clinical benefits that lie within,” Inflammation Research, vol. 56, no. 1, pp. 1–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. D. M. Underhill and A. Ozinsky, “Toll-like receptors: key mediators of microbe detection,” Current Opinion in Immunology, vol. 14, no. 1, pp. 103–110, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. R. Medzhitov, P. Preston-Hurlburt, and C. A. Janeway, “A human homologue of the Drosophila toll protein signals activation of adaptive immunity,” Nature, vol. 388, no. 6640, pp. 394–397, 1997. View at Publisher · View at Google Scholar · View at Scopus
  72. T. E. Mollnes, D. Christiansen, O. L. Brekke, and T. Espevik, “Hypothesis: combined inhibition of complement and cd14 as treatment regimen to attenuate the inflammatory response,” Advances in Experimental Medicine and Biology, vol. 632, pp. 253–263, 2008. View at Google Scholar · View at Scopus
  73. S. Akashi, R. Shimazu, H. Ogata et al., “Cutting edge: cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages,” Journal of Immunology, vol. 164, no. 7, pp. 3471–3475, 2000. View at Google Scholar · View at Scopus
  74. R. Ostuni, I. Zanoni, and F. Granucci, “Deciphering the complexity of Toll-like receptor signaling,” Cellular and Molecular Life Sciences, vol. 67, no. 24, pp. 4109–4134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. J. Asong, M. A. Wolfert, K. K. Maiti, D. Miller, and G. J. Boons, “Binding and cellular activation studies reveal that toll-like receptor 2 can differentially recognize peptidoglycan from gram-positive and gram-negative bacteria,” Journal of Biological Chemistry, vol. 284, no. 13, pp. 8643–8653, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. I. Lesur, J. Textoris, B. Loriod et al., “Gene expression profiles characterize inflammation stages in the acute lung injury in mice,” PLoS ONE, vol. 5, no. 7, Article ID e11485, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. C. Werts, R. I. Tapping, J. C. Mathison et al., “Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism,” Nature Immunology, vol. 2, no. 4, pp. 346–352, 2001. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Hauk, F. Macedo, E. C. Romero et al., “In LipL32, the major leptospiral lipoprotein, the C terminus is the primary immunogenic domain and mediates interaction with collagen IV and plasma fibronectin,” Infection and Immunity, vol. 76, no. 6, pp. 2642–2650, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. D. A. Haake, G. Chao, R. L. Zuerner et al., “The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection,” Infection and Immunity, vol. 68, no. 4, pp. 2276–2285, 2000. View at Publisher · View at Google Scholar · View at Scopus
  80. S. H. Hsu, Y. Y. Lo, J. Y. Tung et al., “Leptospiral outer membrane lipoprotein LipL32 binding on toll-like receptor 2 of renal cells as determined with an atomic force microscope,” Biochemistry, vol. 49, no. 26, pp. 5408–5417, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. G. L. Murray, A. Srikram, D. E. Hoke et al., “Major surface protein LipL32 is not required for either acute or chronic infection with Leptospira interrogans,” Infection and Immunity, vol. 77, no. 3, pp. 952–958, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. H. He, W. Wang, Z. Wu, Z. Lv, J. Li, and L. Tan, “Protection of guinea pigs against Leptospira interrogans serovar Lai by lipL21 DNA vaccine,” Cellular and Molecular Immunology, vol. 5, no. 5, pp. 385–391, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. C. C. Hung, C. T. Chang, Y. C. Tian et al., “Leptospiral membrane proteins stimulate pro-inflammatory chemokines secretion by renal tubule epithelial cells through toll-like receptor 2 and p38 mitogen activated protein kinase,” Nephrology Dialysis Transplantation, vol. 21, no. 4, pp. 898–910, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. C. W. Yang, C. C. Hung, M. S. Wu et al., “Toll-like receptor 2 mediates early inflammation by leptospiral outer membrane proteins in proximal tubule cells,” Kidney International, vol. 69, no. 5, pp. 815–822, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Marinho, I. S. Oliveira-Júnior, C. M. R. Monteiro, S. H. Perri, and R. Salomão, “Pulmonary disease in hamsters infected with Leptospira interrogans: histopathologic findings and cytokine mRNA expressions,” American Journal of Tropical Medicine and Hygiene, vol. 80, no. 5, pp. 832–836, 2009. View at Google Scholar · View at Scopus
  86. C. G. Priya, S. R. Rathinam, and V. Muthukkaruppan, “Evidence for endotoxin as a causative factor for leptospiral uveitis in humans,” Investigative Ophthalmology and Visual Science, vol. 49, no. 12, pp. 5419–5424, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. J. F. P. Wagenaar, M. G. A. Goris, M. H. Gasem et al., “Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis,” Journal of Infection, vol. 58, no. 6, pp. 425–432, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Poltorak, X. He, I. Smirnova et al., “Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene,” Science, vol. 282, no. 5396, pp. 2085–2088, 1998. View at Publisher · View at Google Scholar · View at Scopus
  89. M. M. Pereira, J. Andrade, R. S. Marchevsky, and R. Ribeiro Dos Santos, “Morphological characterization of lung and kidney lesions in C3H/HeJ mice infected with Leptospira interrogans serovar icterohaemorrhagiae: defect of CD4+ and CD8+ T-cells are prognosticators of the disease progression,” Experimental and Toxicologic Pathology, vol. 50, no. 3, pp. 191–198, 1998. View at Google Scholar · View at Scopus
  90. J. B. D. Silva, T. M. V. Ramos, M. de Franco et al., “Chemokines expression during Leptospira interrogans serovar copenhageni infection in resistant BALB/c and susceptible C3H/HeJ mice,” Microbial Pathogenesis, vol. 47, no. 2, pp. 87–93, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. J. E. Nally, M. C. Fishbein, D. R. Blanco, and M. A. Lovett, “Lethal infection of C3H/HeJ and C3H/SCID mice with an isolate of Leptospira interrogans serovar copenhageni,” Infection and Immunity, vol. 73, no. 10, pp. 7014–7017, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Viriyakosol, M. A. Matthias, M. A. Swancutt, T. N. Kirkland, and J. M. Vinetz, “Toll-like receptor 4 protects against lethal Leptospira interrogans serovar icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burden,” Infection and Immunity, vol. 74, no. 2, pp. 887–895, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. R. Murgia, R. Garcia, and M. Cinco, “Leptospires are killed in vitro by both oxygen-dependent and -independent reactions,” Infection and Immunity, vol. 70, no. 12, pp. 7172–7175, 2002. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Cinco, “New insights into the pathogenicity of leptospires: evasion of host defences,” New Microbiologica, vol. 33, no. 4, pp. 283–292, 2010. View at Google Scholar · View at Scopus
  95. M. Cinco and E. Banfi, “Activation of complement by leptospires and its bactericidal activity,” Zentralblatt fur Bakteriologie Mikrobiologie und Hygiene A, vol. 254, no. 2, pp. 261–265, 1983. View at Google Scholar · View at Scopus
  96. T. Meri, R. Murgia, P. Stefanel, S. Meri, and M. Cinco, “Regulation of complement activation at the C3-level by serum resistant leptospires,” Microbial Pathogenesis, vol. 39, no. 4, pp. 139–147, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. M. M. Castiblanco-Valencia, T. R. Fraga, L. B. D. Silva et al., “Leptospiral immunoglobulin-like proteins interact with human complement regulators factor H, FHL-1, FHR-1, and C4BP,” Journal of Infectious Diseases, vol. 205, no. 6, pp. 995–1004, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. H. A. Choy, “Multiple activities of ligb potentiate virulence of Leptospira interrogans: inhibition of alternative and classical pathways of complement,” PLoS ONE, vol. 7, no. 7, Article ID e41566, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. N. M. Souza, M. L. Vieira, I. J. Alves, Z. M. de Morais, S. A. Vasconcellos, and A. L. T. O. Nascimento, “Lsa30, a novel adhesin of Leptospira interrogans binds human plasminogen and the complement regulator C4bp,” Microbial Pathogenesis, vol. 53, no. 3-4, pp. 125–134, 2012. View at Publisher · View at Google Scholar · View at Scopus
  100. R. F. Domingos, M. L. Vieira, E. C. Romero et al., “Features of two proteins of Leptospira interrogans with potential role in host-pathogen interactions,” BMC Microbiology, vol. 12, article 50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. A. S. Barbosa, D. Monaris, L. B. Silva et al., “Functional characterization of LcpA, a surface-exposed protein of Leptospira spp. that binds the human complement regulator C4BP,” Infection and Immunity, vol. 78, no. 7, pp. 3207–3216, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. B. Adler and S. Faine, “Host immunological mechanisms in the resistance of mice to leptospiral infections,” Infection and Immunity, vol. 17, no. 1, pp. 67–72, 1977. View at Google Scholar · View at Scopus
  103. D. A. Haake, M. K. Mazel, A. M. Mccoy et al., “Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection,” Infection and Immunity, vol. 67, no. 12, pp. 6572–6582, 1999. View at Google Scholar · View at Scopus
  104. C. Chassin, M. Picardeau, J. M. Goujon et al., “TLR4- and TLR2-mediated B cell responses control the clearance of the bacterial pathogen, Leptospira interrogans,” Journal of Immunology, vol. 183, no. 4, pp. 2669–2677, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. B. M. Naiman, D. Alt, C. A. Bolin, R. Zuerner, and C. L. Baldwin, “Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and γδ T lymphocytes,” Infection and Immunity, vol. 69, no. 12, pp. 7550–7558, 2001. View at Publisher · View at Google Scholar · View at Scopus
  106. I. Tuero, J. M. Vinetz, and G. R. Kumpel, “Lack of demonstrable memory T cell responses in humans who have spontaneously recovered from leptospirosis in the peruvian amazon,” Journal of Infectious Diseases, vol. 201, no. 3, pp. 420–427, 2010. View at Publisher · View at Google Scholar · View at Scopus
  107. D. R. Finco and D. G. Low, “Endotoxin properties of Leptospira canicola,” American Journal of Veterinary Research, vol. 28, no. 127, pp. 1863–1872, 1967. View at Google Scholar · View at Scopus
  108. R. C. R. M. Abdulkader, E. F. Daher, E. D. Camargo, C. Spinosa, and M. V. Da Silva, “Leptospirosis severity may be associated with the intensity of humoral immune response,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 44, no. 2, pp. 79–83, 2002. View at Google Scholar · View at Scopus
  109. V. Tu, B. Adler, and S. Faine, “The role of macrophages in the protection of mice against leptospirosis: in vitro and in vivo studies,” Pathology, vol. 14, no. 4, pp. 463–468, 1982. View at Google Scholar · View at Scopus
  110. D. Diament, M. K. C. Brunialti, E. C. Romero, E. G. Kallas, and R. Salomao, “Peripheral blood mononuclear cell activation induced by Leptospira interrogans glycolipoprotein,” Infection and Immunity, vol. 70, no. 4, pp. 1677–1683, 2002. View at Publisher · View at Google Scholar · View at Scopus
  111. L. Nieuwenhuizen, P. G. De Groot, J. C. Grutters, and D. H. Biesma, “A review of pulmonary coagulopathy in acute lung injury, acute respiratory distress syndrome and pneumonia,” European Journal of Haematology, vol. 82, no. 6, pp. 413–425, 2009. View at Publisher · View at Google Scholar · View at Scopus
  112. E. Marchiori, S. Lourenço, S. Setúbal, G. Zanetti, T. D. Gasparetto, and B. Hochhegger, “Clinical and imaging manifestations of hemorrhagic pulmonary leptospirosis: a state-of-the-art review,” Lung, vol. 189, no. 1, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  113. H. I. Chen, S. J. Kao, and Y. H. Hsu, “Pathophysiological mechanism of lung injury in patients with leptospirosis,” Pathology, vol. 39, no. 3, pp. 339–344, 2007. View at Publisher · View at Google Scholar · View at Scopus
  114. V. M. Arean, “The pathologic anatomy and pathogenesis of fatal human leptospirosis (Weil's disease),” The American Journal of Pathology, vol. 40, pp. 393–423, 1962. View at Google Scholar · View at Scopus
  115. M. M. Pereira, J. J. Pereira Da Silva, M. A. Pinto et al., “Experimental leptospirosis in marmoset monkeys (Callithrix jacchus): a new model for studies of severe pulmonary leptospirosis,” American Journal of Tropical Medicine and Hygiene, vol. 72, no. 1, pp. 13–20, 2005. View at Google Scholar · View at Scopus
  116. J. Croda, A. N. D. Neto, R. A. Brasil, C. Pagliari, A. C. Nicodemo, and M. I. S. Duarte, “Leptospirosis pulmonary haemorrhage syndrome is associated with linear deposition of immunoglobulin and complement on the alveolar surface,” Clinical Microbiology and Infection, vol. 16, no. 6, pp. 593–599, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. J. I. Sznajder, K. M. Ridge, Z. L. Harris et al., “Alveolar type II cell Na,K-ATPase is upregulated during mechanical ventilation-induced pulmonary edema,” Chest, vol. 105, no. 3, supplement, pp. 116S–117S, 1994. View at Google Scholar · View at Scopus
  118. J. I. Sznajder, “Alveolar edema must be cleared for the acute respiratory distress syndrome patient to survive,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 6, pp. 1293–1294, 2001. View at Google Scholar · View at Scopus
  119. M. A. Matthay, “Alveolar fluid clearance in patients with ARDS: does it make a difference?” Chest, vol. 122, no. 6, supplement, pp. 340S–343S, 2002. View at Google Scholar · View at Scopus
  120. I. Vadász, R. E. Morty, M. G. Kohstall et al., “Oleic acid inhibits alveolar fluid reabsorption: a role in acute respiratory distress syndrome?” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 5, pp. 469–479, 2005. View at Publisher · View at Google Scholar · View at Scopus
  121. C.-W. Yang, M.-S. Wu, and M.-J. Pan, “Leptospirosis renal disease,” Nephrology Dialysis Transplantation, vol. 16, supplement 5, pp. 73–77, 2001. View at Google Scholar · View at Scopus
  122. M. Younes-Ibrahim, B. Buffin-Meyer, L. Cheval et al., “Na,K-ATPase: a molecular target for Leptospira interrogans endotoxin,” Brazilian Journal of Medical and Biological Research, vol. 30, no. 2, pp. 213–223, 1997. View at Google Scholar · View at Scopus
  123. A. I. Ko, C. Goarant, and M. Picardeau, “Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen,” Nature Reviews Microbiology, vol. 7, no. 10, pp. 736–747, 2009. View at Publisher · View at Google Scholar · View at Scopus
  124. A. C. Seguro, A. V. Lomar, and A. S. Rocha, “Acute renal failure of leptospirosis: nonoliguric and hypokalemic forms,” Nephron, vol. 55, no. 2, pp. 146–151, 1990. View at Google Scholar · View at Scopus
  125. L. Andrade, A. C. Rodrigues, T. R. C. Sanches, R. B. Souza, and A. C. Seguro, “Leptospirosis leads to dysregulation of sodium transporters in the kidney and lung,” American Journal of Physiology, vol. 292, no. 2, pp. F586–F592, 2007. View at Publisher · View at Google Scholar · View at Scopus
  126. M. M. Pereira, J. Andrade, M. D. Lacerda, N. M. Batoréu, R. S. Marchevsky, and R. Ribeiro Dos Santos, “Demonstration of leptospiral antigens on tissues using monoclonal antibodies and avidin-biotin peroxidase staining,” Experimental and Toxicologic Pathology, vol. 49, no. 6, pp. 505–511, 1997. View at Google Scholar · View at Scopus
  127. M. Younes-Ibrahim, P. Burth, M. V. Castro Faria et al., “Inhibition of Na,K-ATPase by an endotoxin extracted from Leptospira interrogans: a possible mechanism for the physiopathology of leptospirosis,” Comptes Rendus de l'Academie des Sciences III, vol. 318, no. 5, pp. 619–625, 1995. View at Google Scholar · View at Scopus
  128. P. Burth, M. Younes-Ibrahim, M. C. B. Santos, H. C. Castro-Faria Neto, and M. V. De Castro Faria, “Role of nonesterified unsaturated fatty acids in the pathophysiological processes of leptospiral infection,” Journal of Infectious Diseases, vol. 191, no. 1, pp. 51–57, 2005. View at Publisher · View at Google Scholar · View at Scopus
  129. G. Boden, P. She, M. Mozzoli et al., “Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-κb pathway in rat liver,” Diabetes, vol. 54, no. 12, pp. 3458–3465, 2005. View at Publisher · View at Google Scholar · View at Scopus
  130. L. G. Wood, H. A. Scott, M. L. Garg, and P. G. Gibson, “Innate immune mechanisms linking non-esterified fatty acids and respiratory disease,” Progress in Lipid Research, vol. 48, no. 1, pp. 27–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  131. T. Martins De Lima, R. Gorjão, E. Hatanaka et al., “Mechanisms by which fatty acids regulate leucocyte function,” Clinical Science, vol. 113, no. 1-2, pp. 65–77, 2007. View at Publisher · View at Google Scholar · View at Scopus
  132. A. R. Weatherill, J. Y. Lee, L. Zhao, D. G. Lemay, H. S. Youn, and D. H. Hwang, “Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4,” Journal of Immunology, vol. 174, no. 9, pp. 5390–5397, 2005. View at Google Scholar · View at Scopus
  133. J. Y. Lee, J. Ye, Z. Gao et al., “Reciprocal modulation of toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids,” Journal of Biological Chemistry, vol. 278, no. 39, pp. 37041–37051, 2003. View at Publisher · View at Google Scholar · View at Scopus
  134. S. S. Chi, I. G. Tikhonova, S. Neumann et al., “Identification of residues important for agonist recognition and activation in GPR40,” Journal of Biological Chemistry, vol. 282, no. 40, pp. 29248–29255, 2007. View at Publisher · View at Google Scholar · View at Scopus
  135. S. Costanzi, S. Neumann, and M. C. Gershengorn, “Seven transmembrane-spanning receptors for free fatty acids as therapeutic targets for diabetes mellitus: pharmacological, phylogenetic, and drug discovery aspects,” Journal of Biological Chemistry, vol. 283, no. 24, pp. 16269–16273, 2008. View at Publisher · View at Google Scholar · View at Scopus
  136. M. Toborek, Y. W. Lee, R. Garrido, S. Kaiser, and B. Hennig, “Unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cell,” American Journal of Clinical Nutrition, vol. 75, no. 1, pp. 119–125, 2002. View at Google Scholar · View at Scopus
  137. A. Y. Bagrov, J. I. Shapiro, and O. V. Fedorova, “Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets,” Pharmacological Reviews, vol. 61, no. 1, pp. 9–38, 2009. View at Publisher · View at Google Scholar · View at Scopus
  138. Z. Xie and T. Cai, “Na+-K+–ATPase-mediated signal transduction: from protein interaction to cellular function,” Mol Interv, vol. 3, no. 3, pp. 157–168, 2003. View at Google Scholar · View at Scopus
  139. J. Tian and Z. J. Xie, “The Na-K-ATPase and calcium-signaling microdomains,” Physiology, vol. 23, no. 4, pp. 205–211, 2008. View at Publisher · View at Google Scholar · View at Scopus
  140. A. Aperia, “New roles for an old enzyme: Na,K-ATPase emerges as an interesting drug target,” Journal of Internal Medicine, vol. 261, no. 1, pp. 44–52, 2007. View at Publisher · View at Google Scholar · View at Scopus
  141. A. Miyakawa-Naito, P. Uhlén, M. Lal et al., “Cell signaling microdomain with Na,K-ATPase and inositol 1,4,5-trisphosphate receptor generates calcium oscillations,” Journal of Biological Chemistry, vol. 278, no. 50, pp. 50355–50361, 2003. View at Publisher · View at Google Scholar · View at Scopus
  142. M. Nesher, U. Shpolansky, H. Rosen, and D. Lichtstein, “The digitalis-like steroid hormones: new mechanisms of action and biological significance,” Life Sciences, vol. 80, no. 23, pp. 2093–2107, 2007. View at Publisher · View at Google Scholar · View at Scopus
  143. M. Liang, J. Tian, L. Liu et al., “Identification of a pool of non-pumping Na/K-ATPase,” Journal of Biological Chemistry, vol. 282, no. 14, pp. 10585–10593, 2007. View at Publisher · View at Google Scholar · View at Scopus
  144. S. Rodrigues-Mascarenhas, A. D. S. De Oliveira, N. D. Amoedo, O. R. Affonso-Mitidieri, F. D. Rumjanek, and V. M. Rumjanek, “Modulation of the immune system by ouabain,” Annals of the New York Academy of Sciences, vol. 1153, pp. 153–163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  145. A. D. Foey, A. Crawford, and N. D. Hall, “Modulation of cytokine production by human mononuclear cells following impairment of Na,K-ATPase activity,” Biochimica et Biophysica Acta, vol. 1355, no. 1, pp. 43–49, 1997. View at Publisher · View at Google Scholar · View at Scopus
  146. E. Blasi, A. Ardizzoni, B. Colombari et al., “NF-kB activation and p38 phosphorilation in microglial cells infected with Leptospira or exposed to partially purified leptospiral lipoproteins,” Microbial Pathogenesis, vol. 42, no. 2-3, pp. 80–87, 2007. View at Publisher · View at Google Scholar · View at Scopus
  147. M. Cinco, E. Vecile, R. Murgia, P. Dobrina, and A. Dobrina, “Leptospira interrogans and Leptospira peptidoglycans induce the release of tumor necrosis factor α from human monocytes,” FEMS Microbiology Letters, vol. 138, no. 2-3, pp. 211–214, 1996. View at Publisher · View at Google Scholar · View at Scopus
  148. P. Burth, M. Younes-Ibrahim, F. H. F. S. Goncalez, E. R. Costa, and M. V. C. Faria, “Purification and characterization of a Na+,K+ ATPase inhibitor found in an endotoxin of Leptospira interrogans,” Infection and Immunity, vol. 65, no. 4, pp. 1557–1560, 1997. View at Google Scholar · View at Scopus
  149. M. H. Tajiki and R. Salonião, “Association of plasma levels of tumor necrosis factor α with severity of disease and mortality among patients with leptospirosis,” Clinical Infectious Diseases, vol. 23, no. 5, pp. 1177–1178, 1996. View at Google Scholar · View at Scopus
  150. F. Martinon, K. Burns, and J. Tschopp, “The Inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β,” Molecular Cell, vol. 10, no. 2, pp. 417–426, 2002. View at Publisher · View at Google Scholar · View at Scopus
  151. S. Akira, S. Uematsu, and O. Takeuchi, “Pathogen recognition and innate immunity,” Cell, vol. 124, no. 4, pp. 783–801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  152. S. Lacroix-Lamandé, M. F. D'Andon, E. Michel et al., “Downregulation of the Na/K-ATPase pump by leptospiral glycolipoprotein activates the NLRP3 inflammasome,” Journal of Immunology, vol. 188, no. 6, pp. 2805–2814, 2012. View at Publisher · View at Google Scholar · View at Scopus